1. Department of Internal Medicine, Mae Sot General Hospital, Mae Sot, Thailand;
2. Shoklo Malaria Research Unit, Mahidol–Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand;
3. GlaxoSmithKline Research and Development Ltd., Uxbridge, United Kingdom;
4. GlaxoSmithKline, Research Triangle Park, North Carolina;
5. Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand;
6. Medicines for Malaria Venture, Geneva, Switzerland;
7. GlaxoSmithKline, Bangkok, Thailand;
8. GlaxoSmithKline, King of Prussia, Pennsylvania;
9. Department of Hematology and Blood Transfusion, Muhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania
10. Istituto Toscano Tumori, Florence, Italy;